Triamcinolone Acetonide Lotion Recalled for cGMP Deviations
Teligent Pharma is recalling all unexpired batches of Triamcinolone Acetonide Lotion USP 0.025% due to current Good Manufacturing Practice (cGMP) deviations related to discontinuation of the stability study program.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is a manufacturing practice deviation (discontinuation of stability studies), which is a precautionary compliance issue rather than an immediate documented health threat.
Plain-English summary
Teligent Pharma, Inc., of Buena, New Jersey, is recalling Triamcinolone Acetonide Lotion USP, 0.025%, supplied in 60 mL (60 grams) bottles, NDC 52565-010-59. The recall affects approximately 112,769 bottles distributed nationwide in the USA and Puerto Rico.
The recall is issued because the firm is discontinuing its stability study program, which constitutes a deviation from current Good Manufacturing Practice (cGMP) standards. All products within their expiration dates are included in this recall.
Affected batches include: 14796 (Exp. 12/31/2022), 14797 (Exp. 1/31/2023), 14534, 15571, 15572 (Exp. 4/30/2023), 15746, 15756 (Exp. 6/30/2023), 15982 (Exp. 9/30/2023), 16043, 16144, 16149 (Exp. 10/31/2023), 16433, 16434 (Exp. 2/29/2024), 16656, 16679 (Exp. 3/31/2024), and 16784 (Exp. 5/31/2024).
Patients and healthcare providers should discontinue use of affected batches and consult with their healthcare provider regarding alternative treatment options. The product is prescription-only (Rx only).
The recalled product
- Product
- Triamcinolone Acetonide Lotion USP, 0.025%, 60 mL (60 grams) bottle, Rx only, Teligent Pharma, Inc., Buena, New Jersey 08310, NDC 52565-010-59.
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical Steroid
- Affected units
- 112,769
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Batch: 14796
- Exp. 12/31/2022
- 14797
- Exp. 1/31/2023
- 14534
- 15571
- 15572
- Exp. 4/30/2023
- 15746
- 15756
- Exp. 6/30/2023
- 15982
- Exp. 9/30/2023
- 16043
- 16144
- 16149
- Exp. 10/31/2023
- 16433
- 16434
- Exp. 2/29/2024
Distribution
Part of a larger recall action
This product is one of 37 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Teligent Pharma, Inc.
See all →- ModerateDesonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Cream USP 0.1% Recall — Stability Study Discontinuation
FDA (Drugs) · 2022-03-30
- ModerateTriamcinolone Acetonide Ointment Recalled Due to cGMP Deviations
FDA (Drugs) · 2022-03-30
- HighDiflorasone Diacetate Ointment recalled due to discontinued stability studies
FDA (Drugs) · 2022-03-30
- ModerateClobetasol Propionate Cream USP 0.05% Recall for cGMP Deviations
FDA (Drugs) · 2022-03-30
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate USP Recalled for CGMP Deviations Noted During FDA Inspection
FDA (Drugs) · 2026-08-19
- ModerateSildenafil Citrate Recall Due to CGMP Deviations
FDA (Drugs) · 2026-08-19